SBIR/STTR Research Award

STTR Phase I: Emulating Biological Actuation

Award identifier 0ce26d21759dbd93c3c8b7d256e92e53e024c4bda3a72bc7139b80d6f25907d6Awarding agency National Science Foundation

Award amount

$224,009

Program and phase

STTR · Phase I

Award year

2015

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
National Science Foundation
Branch
Not reported
Recipient company
iWalk, Inc.
Proposal award date
2015-07-01
Contract end date
2016-06-30
UEI
GEMQX5KSTMZ7
Solicitation number
Not reported
Topic code
EW

Research abstract

The broader impact/commercial potential of this project includes development of robust control algorithms for a robotic, foot-ankle prosthesis based on the winding filament hypothesis, a transformative new idea about how muscles contract. The winding filament hypothesis is uniquely able to account for properties of muscles that allow instantaneous and automatic adaptation of stiffness to unexpected changes in load. In the U.S. today, 1.6 -1.8 million persons live with loss of a limb. Despite the success of the latest technological improvements, significant challenges remain in development of robotic prostheses and other assistive devices. No devices available on the market today can reproduce normal walking movements under variable conditions (e.g., sand or other compliant substrates, stairs, steep ramps). These limitations affect quality of life by limiting participation in activities of daily life, including maintenance of physical fitness. Benefits of a robust powered prosthesis include increased versatility from level walking at a range of speeds, to stairs, ramps and varied terrain. The technology could also be extended to ankle orthoses for people whose mobility is limited by stroke, diabetes, or other conditions of disease and aging. In addition, development of bio-inspired control algorithms will enhance the scientific and technological understanding of muscle-like actuation. This Small Business Technology Transfer Research (STTR) Phase I project involves collaboration between a leading provider of robotic foot-ankle prostheses for persons with a lower limb amputation, and developers of the winding filament hypothesis, a transformative new idea about how muscles contract. The goal of the project is to demonstrate the technical and commercial feasibility of developing a robust control algorithm for a robotic prosthesis, based on the winding filament hypothesis. A powered, foot-ankle prosthesis will be modified to accommodate the bio-inspired control algorithms, the algorithms will be modified to account for prosthesis properties, and performance will be optimized for a broad range of terrains and conditions, including ramps, stairs and compliant surfaces. If the winding filament hypothesis algorithm can outperform the stock prosthesis controller in the range of conditions under which it emulates normal walking, this would provide proof-of-concept that a robust prosthesis controller is technically and commercially feasible. Robust control represents a disruptive market advance not only for prosthesis technology, but also for orthotic devices. A more versatile prosthesis would improve the quality of life for millions of Americans with limb loss.

Technology keywords

Not reported

Agency intelligence

National Science Foundation

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.